ABT - Abbott Laboratories
This page shows which of the focused investors we track hold ABT and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2013 it was held by 12 managers with an aggregate reported value of $1.36B, which is 0.19% of the combined portfolio.
As of Q4 2013, 12 tracked institutional managers held ABT (Abbott Laboratories) with an aggregate reported value of $1.36B — 0.19% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ABT — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2013
- Ticker
- ABT
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Mason Hawkins - Southeastern Asset Management | 2.52% | Reduce -2.1% | 13,445,344 | $515.36M |
| 2 | Polen Capital Management - Polen Capital Management | 6.48% | Add +22.4% | 7,642,439 | $292.94M |
| 3 | Richard Pzena - Pzena Investment Management | 1.44% | Reduce -0.3% | 6,426,564 | $246.33M |
| 4 | Jensen Investment Management - Jensen Investment Management | 1.79% | Reduce -41.9% | 3,283,910 | $125.87M |
| 5 | Daniel Loeb - Third Point | 2.36% | New | 3,250,000 | $124.57M |
| 6 | Steven Check - Check Capital Management | 2.62% | Add +9.7% | 451,886 | $17.32M |
| 7 | Valley Forge Capital Management - Valley Forge Capital Management | 1.37% | Reduce -37.9% | 371,334 | $14.23M |
| 8 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.21% | Add +3.7% | 351,373 | $13.47M |
| 9 | Robert Olstein - Olstein Capital Management | 0.98% | Add +23.4% | 179,000 | $6.86M |
| 10 | Thomas Russo - Gardner Russo & Quinn | 0.03% | - | 86,503 | $3.32M |
| 11 | Bill Nygren - Oakmark Funds | 0.00% | - | 44,178 | $1.69M |
| 12 | Dodge & Cox - Dodge & Cox | 0.00% | - | 36,930 | $1.42M |
Loading holder history for ABT…